Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.58 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.58 |
| ▸ | TERT | O14746 | 3/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.56 |
| ▸ | PPARG | P37231 | 3/20 | 0.56 |
| ▸ | PPARD | Q03181 | 3/20 | 0.56 |
| ▸ | PPARA | Q07869 | 3/20 | 0.56 |
| ▸ | TOP1 | P11387 | 3/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.56 |
| ▸ | BLM | P54132 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | FABP4 | P15090 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | GMNN | O75496 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20178791 | 1.00 | FAAH (0.58) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL294780 | 1.00 | FAAH (0.58) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL2971122 | 1.00 | FAAH (0.58) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL2971125 | 1.00 | FAAH (0.58) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL2974048 | 1.00 | FAAH (0.58) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL3491409 | 1.00 | FAAH (0.58) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL1245079 | 1.00 | FAAH (0.58) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL1265793 | 1.00 | FAAH (0.58) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL5519456 | 1.00 | FAAH (0.58) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL295522 | 1.00 | FAAH (0.58) | FAAHTRPV1TERTPTPN1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5677155-A | Process for preparing the sex pheromone of Lymantria dispar L | NITTO DENKO CO., LTD. (JP) | 1997-10-14 | — | — | US | claimed |
| JP-8131187-A | — | — | None | — | — | JP | disclosed |
| US-20240410055-A1 | METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS | MERCK PATENT GMBH (DE) | 2024-12-12 | — | — | US | disclosed |
| CN-118076767-A | Method and formulation for producing an optical metal oxide layer | 默克专利有限公司 | 2024-05-24 | — | — | CN | disclosed |
| US-20240050378-A1 | LIPID NANOPARTICLE COMPOSITIONS CONTAINING MONOESTER CATIONIC LIPIDS | MERCK SHARP & DOHME LLC (US) | 2024-02-15 | — | — | US | disclosed |
| EP-4255888-A2 | LIPID NANOPARTICLE COMPOSITIONS CONTAINING MONOESTER CATIONIC LIPIDS | Merck Sharp & Dohme LLC (US) | 2023-10-11 | — | — | EP | disclosed |
| CN-116685356-A | Lipid nanoparticle compositions containing monoester cationic lipids | 默沙东有限责任公司 | 2023-09-01 | — | — | CN | disclosed |
| US-20230256098-A1 | BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS | BANK OF AMERICA, N.A. | 2023-08-17 | — | — | US | disclosed |
| US-20230256098-A1 | BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS | BANK OF AMERICA, N.A. | 2023-08-17 | — | — | US | disclosed |
| US-11679158-B2 | Biodegradable lipids for the delivery of active agents | ALNYLAM PHARMACEUTICALS, INC. (US) | 2023-06-20 | — | — | US | disclosed |
| US-5677155-A | Process for preparing the sex pheromone of Lymantria dispar L | NITTO DENKO CO., LTD. (JP) | 1997-10-14 | — | — | US | disclosed |
| US-5677155-A | Process for preparing the sex pheromone of Lymantria dispar L | NITTO DENKO CO., LTD. (JP) | 1997-10-14 | — | — | US | disclosed |
| JP-H08131187-A | SEX PHEROMONE OF LYMANTRIA DISPAR L. | NITTO DENKO CORP | 1996-05-28 | — | — | JP | disclosed |
| US-5492964-A | HYDROGENATION CATALYSTS | UNIVERSITY OF SOUTH CAROLINA (US) | 1996-02-20 | — | — | US | disclosed |
| WO-1993025521-A1 | ARYL ALIPHATIC ACIDS | BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) | 1993-12-23 | — | — | WO | disclosed |
| US-5238832-A | Lipoxygenase inhibitors | BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) | 1993-08-24 | — | — | US | disclosed |
| WO-1991014500-A1 | CERAMIC MATERIALS, METHOD OF PREPARING THE SAME AND HYDROGENATION AND OXIDATION PROCESSES USING THE SAME | UNIVERSITY OF SOUTH CAROLINA (US) | 1991-10-03 | — | — | WO | disclosed |
| US-4394326-A | Preparation of alkenoxy aluminum compounds and compounds produced | TEXAS ALKYLS, INC. (US) | 1983-07-19 | — | — | US | disclosed |
| US-4341910-A | Preparation of unsaturated alcohols | TEXAS ALKYLS, INC. (US) | 1982-07-27 | — | — | US | disclosed |
| EP-0014846-A1 | Preparation of 2-alken-1-ols and their production | TEXAS ALKYLS, INC. (US) | 1980-09-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240050378-A1 | LIPID NANOPARTICLE COMPOSITIONS CONTAINING MONOESTER CATIONIC LIPIDS | LIPA, LIPC, MGLL | FAAH 1067/4885TRPV1 2221/4885TERT 1642/4885 |
| US-11679158-B2 | Biodegradable lipids for the delivery of active agents | LIPA, APOB, CETP | FAAH 808/4885TRPV1 3471/4885TERT 1916/4885 |
| US-20230256098-A1 | BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS | LIPA, APOB, CETP | FAAH 808/4885TRPV1 3471/4885TERT 1916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.